Limits...
Evaluation of anticataract potential of Triphala in selenite-induced cataract: In vitro and in vivo studies.

Gupta SK, Kalaiselvan V, Srivastava S, Agrawal SS, Saxena R - J Ayurveda Integr Med (2010)

Bottom Line: TP significantly (P < 0.01) restored GSH and decreased malondialdehyde levels.A significant restoration in the activities of antioxidant enzymes such as superoxide dismutase (P < 0.05), catalase (P < 0.05), glutathione peroxidase (P < 0.05), and glutathione-s-transferase (P < 0.005) was observed in the TP-supplemented group compared to controls.This effect may be due to antioxidant activity.

View Article: PubMed Central - PubMed

Affiliation: Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, India.

ABSTRACT
Triphala (TP) is composed of Emblica officinalis, Terminalia chebula, and Terminalia belerica. The present study was undertaken to evaluate its anticataract potential in vitro and in vivo in a selenite-induced experimental model of cataract. In vitro enucleated rat lenses were maintained in organ culture containing Dulbecco's Modified Eagles Medium alone or with the addition of 100μM selenite. These served as the normal and control groups, respectively. In the test group, the medium was supplemented with selenite and different concentrations of TP aqueous extract. The lenses were incubated for 24 h at 37°C. After incubation, the lenses were processed to estimate reduced glutathione (GSH), lipid peroxidation product, and antioxidant enzymes. In vivo selenite cataract was induced in 9-day-old rat pups by subcutaneous injection of sodium selenite (25 μmole/kg body weight). The test groups received 25, 50, and 75 mg/kg of TP intraperitoneally 4 h before the selenite challenge. At the end of the study period, the rats' eyes were examined by slit-lamp. TP significantly (P < 0.01) restored GSH and decreased malondialdehyde levels. A significant restoration in the activities of antioxidant enzymes such as superoxide dismutase (P < 0.05), catalase (P < 0.05), glutathione peroxidase (P < 0.05), and glutathione-s-transferase (P < 0.005) was observed in the TP-supplemented group compared to controls. In vivo TF 25mg/kg developed only 20% nuclear cataract as compared to 100% in control. TP prevents or retards experimental selenite-induced cataract. This effect may be due to antioxidant activity. Further studies are warranted to explore its role in human cataract.

No MeSH data available.


Related in: MedlinePlus

Effect of Triphala on selenite cataract in rat pups, Control: Sodium selenite Treated 1: Sodium selenite-Triphala 25 mg/kg, Treated 2: Sodium selenite-Triphaia 50mg/kg and Treated 3: Sodium selenite-Triphala 75 mg/kg, **P<0.005 (Control vs treated) n**12.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC3117320&req=5

Figure 0006: Effect of Triphala on selenite cataract in rat pups, Control: Sodium selenite Treated 1: Sodium selenite-Triphala 25 mg/kg, Treated 2: Sodium selenite-Triphaia 50mg/kg and Treated 3: Sodium selenite-Triphala 75 mg/kg, **P<0.005 (Control vs treated) n**12.

Mentions: Different grades of selenite cataracts are demonstrated in Figure 5. Subcutaneous injection of μmol concentrations of sodium selenite led to the development of 100% nuclear opacities in the eyes of the control group on postnatal day 18. Of these, 4.2% of the eyes developed pinpoint opacity and 95.8% developed nuclear cataract. In contrast Triphala 25mg/kg led to 60% of the eyes being clear, 20% with pinpoint opacity, and only 20% developing nuclear cataract. Triphala 50 mg/kg resulted in 28% of the eyes being clear, 66.5% with nuclear cataract, and 5.5% with pinpoint opacity. In case of Triphala 100mg/kg, none of the eyes were clear whereas 60% nuclear cataract and 40% pinpoint opacity [Figure 6].


Evaluation of anticataract potential of Triphala in selenite-induced cataract: In vitro and in vivo studies.

Gupta SK, Kalaiselvan V, Srivastava S, Agrawal SS, Saxena R - J Ayurveda Integr Med (2010)

Effect of Triphala on selenite cataract in rat pups, Control: Sodium selenite Treated 1: Sodium selenite-Triphala 25 mg/kg, Treated 2: Sodium selenite-Triphaia 50mg/kg and Treated 3: Sodium selenite-Triphala 75 mg/kg, **P<0.005 (Control vs treated) n**12.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC3117320&req=5

Figure 0006: Effect of Triphala on selenite cataract in rat pups, Control: Sodium selenite Treated 1: Sodium selenite-Triphala 25 mg/kg, Treated 2: Sodium selenite-Triphaia 50mg/kg and Treated 3: Sodium selenite-Triphala 75 mg/kg, **P<0.005 (Control vs treated) n**12.
Mentions: Different grades of selenite cataracts are demonstrated in Figure 5. Subcutaneous injection of μmol concentrations of sodium selenite led to the development of 100% nuclear opacities in the eyes of the control group on postnatal day 18. Of these, 4.2% of the eyes developed pinpoint opacity and 95.8% developed nuclear cataract. In contrast Triphala 25mg/kg led to 60% of the eyes being clear, 20% with pinpoint opacity, and only 20% developing nuclear cataract. Triphala 50 mg/kg resulted in 28% of the eyes being clear, 66.5% with nuclear cataract, and 5.5% with pinpoint opacity. In case of Triphala 100mg/kg, none of the eyes were clear whereas 60% nuclear cataract and 40% pinpoint opacity [Figure 6].

Bottom Line: TP significantly (P < 0.01) restored GSH and decreased malondialdehyde levels.A significant restoration in the activities of antioxidant enzymes such as superoxide dismutase (P < 0.05), catalase (P < 0.05), glutathione peroxidase (P < 0.05), and glutathione-s-transferase (P < 0.005) was observed in the TP-supplemented group compared to controls.This effect may be due to antioxidant activity.

View Article: PubMed Central - PubMed

Affiliation: Delhi Institute of Pharmaceutical Sciences and Research, New Delhi, India.

ABSTRACT
Triphala (TP) is composed of Emblica officinalis, Terminalia chebula, and Terminalia belerica. The present study was undertaken to evaluate its anticataract potential in vitro and in vivo in a selenite-induced experimental model of cataract. In vitro enucleated rat lenses were maintained in organ culture containing Dulbecco's Modified Eagles Medium alone or with the addition of 100μM selenite. These served as the normal and control groups, respectively. In the test group, the medium was supplemented with selenite and different concentrations of TP aqueous extract. The lenses were incubated for 24 h at 37°C. After incubation, the lenses were processed to estimate reduced glutathione (GSH), lipid peroxidation product, and antioxidant enzymes. In vivo selenite cataract was induced in 9-day-old rat pups by subcutaneous injection of sodium selenite (25 μmole/kg body weight). The test groups received 25, 50, and 75 mg/kg of TP intraperitoneally 4 h before the selenite challenge. At the end of the study period, the rats' eyes were examined by slit-lamp. TP significantly (P < 0.01) restored GSH and decreased malondialdehyde levels. A significant restoration in the activities of antioxidant enzymes such as superoxide dismutase (P < 0.05), catalase (P < 0.05), glutathione peroxidase (P < 0.05), and glutathione-s-transferase (P < 0.005) was observed in the TP-supplemented group compared to controls. In vivo TF 25mg/kg developed only 20% nuclear cataract as compared to 100% in control. TP prevents or retards experimental selenite-induced cataract. This effect may be due to antioxidant activity. Further studies are warranted to explore its role in human cataract.

No MeSH data available.


Related in: MedlinePlus